News

Versus Systems Inc. (NASDAQ:VS) shares are trading higher premarket on Friday. On Thursday, the company expanded into Brazil to strengthen its international presence. Also, the company plans to enhance its gamification platform’s impact on audience engagement across industries. Versus Systems has appointed Flavio Maria as the Country Manager for Brazil, one of the largest global gaming markets with over 100 million users. Luis Goldner, Chief Executive Officer of Versus Systems said, “We’re thril

Antitrust regulators have reached a deal with Welsh, Carson, Anderson and Stowe that doesn’t penalize the private equity firm for rolling up the market for anesthesia services in Texas, but tries to prevent it from happening again.

iCapital's Investor Passport aims to streamline compliance and onboarding, saving time and costs in private markets.

Financial markets are betting China will not use the yuan as a policy tool to offset expected U.S. tariffs in a second Donald Trump presidency, based on a view that sharp depreciation like that seen in his first term will be more harmful than helpful to the struggling economy. From the pricing of yuan forwards to interest rate derivatives and analysts' forecasts, indications are that China is already permitting a slow depreciation of the yuan to adjust to a broadly stronger dollar as it braces for Trump 2.0. But pricing also shows investors are expecting a gradual, moderate depreciation, with sell-side analysts seeing a 5-6% drop from current levels by year end.

Capital Markets secured the top position by value, advising on deals worth a total of $8.7bn.

AstraZeneca’s Fasenra, an IL-5-targeting monoclonal antibody already approved for asthma, represents a promising contender for market share in COPD.

Emboldened by a friendlier incoming Trump administration and their success last year in weakening draft capital hikes, big U.S. banks plan to push to overhaul other U.S. capital rules, according to industry executives. Among the industry's goals are to lock in a much weaker version of the "Basel Endgame" capital rule, reduce a capital surcharge levied on global banks, re-work a key leverage constraint, and overhaul the Federal Reserve's annual "stress tests" which assess whether a bank could withstand an economic shock, said three executives with knowledge of the ambitious lobbying plan. Under President-elect Donald Trump's first term, global U.S. banks scored some de-regulatory wins, including loosening trading rules and simplifying the stress tests, but they did not win a hoped-for comprehensive review of big bank capital rules implemented following the 2007-2009 global financial crisis.